Multi-targeted RNAi therapeutics for scarless wound healing of skin
US8735567B2 · kind B2 · utility
1Cited by
0References
12Claims
0Family size
Inventors
Key dates
| Filing date | Nov 6, 2008 |
| Grant date | May 27, 2014 |
| Priority date | — |
| Expiry date | Jul 13, 2029 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2310/14
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides small interfering RNA (siRNA) molecules, compositions containing them, and methods of using them for improvement of skin scarless wound healing and other skin conditions, such as psoriasis and lupus-caused cutaneous lesions. The invention includes siRNA molecules and compositions containing them that inhibit the expression of one or more genes that promote pathological or undesired processes in wound healing and methods of using them.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.